Decision making of iatrogenic coronary embolism after SAVR: a case report

Atsuyuki Mitsuishi1, Kazumasa Orihashi2, Yujiro Miura3

  • 1Department of Cardiovascular Surgery, Kochi Medical School Hospital, 185-1, Kohasu, Nankoku-shi, Okohmachi, Kochi Prefecture, 783-8505, Japan. atmitsu@kochi-u.ac.jp.

PubMed

Insights

Transesophageal echocardiography (TEE) aided in diagnosing coronary artery obstruction post-aortic valve replacement, guiding successful percutaneous coronary intervention (PCI) over traditional bypass surgery.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Diagnostic Imaging

Background:

  • Acute coronary artery obstruction is a rare, life-threatening complication following surgical aortic valve replacement (SAVR).
  • Embolization of native tissue or perivalvular material can cause this obstruction.
  • Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are primary treatments, but PCI feasibility is challenging to assess intraoperatively.

Observation:

  • An 86-year-old woman with severe aortic stenosis underwent SAVR due to comorbidities.
  • Post-cardiopulmonary bypass, coronary artery occlusion was suspected based on electrocardiogram (ECG) changes and new mitral regurgitation.
  • Transesophageal echocardiography (TEE) identified coronary obstruction due to embolus.

Findings:

  • TEE accurately diagnosed coronary artery stenosis caused by an embolus.
  • The imaging modality helped determine the feasibility of PCI.
  • Successful PCI restored coronary perfusion, avoiding more invasive procedures.

Implications:

  • TEE is crucial for diagnosing and guiding treatment of coronary obstruction post-SAVR.
  • This approach facilitates the selection of less invasive PCI over CABG.
  • TEE is particularly valuable when CABG is complex or requires conversion to a less minimally invasive surgical approach.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...